ADIAL PHARMACEUTICALS
Adial Pharmaceuticals engages in the development of prescription medications for addiction and related disorders in the United States. The company's research pipeline includes AD04, a compound that completed the Phase IIb study for the treatment of alcohol use disorders; and AD01, which completed the Phase I clinical-stage for treating addictive behaviors.
ADIAL PHARMACEUTICALS
Industry:
Addiction Treatment Biotechnology Health Care Pharmaceutical
Founded:
2010-01-01
Address:
Charlottesville, Virginia, United States
Country:
United States
Website Url:
http://www.adialpharma.com
Total Employee:
11+
Status:
Active
Contact:
434-422-9800
Total Funding:
34.32 M USD
Technology used in webpage:
Amazon Facebook Sharer Amazon California Region
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
TowerView Health
TowerView Health develops an application for patients to manage medications.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Current Advisors List
Board_member
2015-02-01
Board_member
2014-09-01
Board_member
Board_member
2014-09-01
Board_member
2017-07-01
Board_member
2016-04-01
Board_member
2021-11-01
Current Employees Featured
Cary Claiborne Chief Executive Officer @ Adial Pharmaceuticals
Chief Executive Officer
2022-08-01
Bankole Johnson Chairman @ Adial Pharmaceuticals
Chairman
Robert S. Capon Vice Chairman @ Adial Pharmaceuticals
Vice Chairman
Tony Goodman Chief Operating Officer @ Adial Pharmaceuticals
Chief Operating Officer
2024-01-01
Founder
Stock Details
Investors List
Keystone Capital Partners
Keystone Capital Partners investment in Post-IPO Equity - Adial Pharmaceuticals
Richard Gilliam
Richard Gilliam investment in Post-IPO Equity - Adial Pharmaceuticals
Bespoke Growth Partners
Bespoke Growth Partners investment in Post-IPO Equity - Adial Pharmaceuticals
Keystone Capital Partners
Keystone Capital Partners investment in Post-IPO Equity - Adial Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2024-01-18 | Adial Pharmaceuticals appoints Tony Goodman as COO |
| 2022-08-22 | Adial Pharmaceuticals Names Cary Claiborne as Chief Executive Officer |
Official Site Inspections
http://www.adialpharma.com
- Host name: 172.67.178.165
- IP address: 172.67.178.165
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Adial Pharmaceuticals"
Company – Adial Pharmaceuticals Inc.
Adial History. Adial Pharmaceuticals was founded in 2010, following pioneering research into the genetics of addiction that began in the 1990s. The research focused on the potential of a …See details»
Adial Pharmaceuticals - Crunchbase Company Profile
Organization. Adial Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. …See details»
Company Info – Adial Pharmaceuticals Inc.
Adial Pharma Contact Adial Pharmaceuticals, Inc. 4870 Sadler Road, Suite 300 Glen Allen, VA 23060 T: 1-804-487-8196 info@adialpharma.comSee details»
Adial Pharmaceuticals Inc. | MANAGEMENT
William B. Stilley has served as our Chief Executive Officer since co-founding the company in December 2010. Prior to joining Adial Pharmaceuticals, he was the Vice President, Business …See details»
Adial Pharmaceuticals Inc. | BOARD OF DIRECTORS
He has guest lectured at the Darden School of Business in two courses on the management of life science companies, and serves on the Advisory Board of Virginia BIO, the statewide …See details»
Adial Pharmaceuticals
Mar 28, 2025 Adial Pharmaceuticals was founded in 2007 by Founding Chairman and CEO, William Stilley, M.D. The Company focuses on researching, developing and commercializing …See details»
Adial Pharmaceuticals - Org Chart, Teams, Culture & Jobs - The Org
View Adial Pharmaceuticals' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Adial Pharmaceuticals Inc - Company Profile - GlobalData
Website www.adialpharma.com Telephone 1 434 4229800. No of Employees 4. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange ADIL (NASD) EPS XYZ. Net …See details»
Adial Pharmaceuticals (NASDAQ: ADIL) - LinkedIn
Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions. The Company’s lead investigational new drug product, AD04, is a ...See details»
Adial Pharmaceuticals Inc. | ABOUT
Adial Pharmaceuticals was founded on November 23, 2010 in Charlottesville, Virginia to develop and commercialize medications for the treatment of addictions and related disorders.See details»
Adial Pharmaceuticals - Overview, News & Similar companies
Nov 16, 2024 Adial Pharmaceuticals Granted Key U.S. Patent for the Treatment of Alcohol and Drug Dependence Based on Expanded Genotype Combinations GLEN ALLEN, Va., Dec. 03, …See details»
Adial Pharmaceuticals, Inc - Cruelty Free Investing
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic agents for the treatment of alcohol use disorders. Its lead product …See details»
Adial Pharmaceuticals: Revenue, Worth, Valuation & Competitors …
About Adial Pharmaceuticals. Adial Pharmaceuticals is an Other related company founded in 2010 and based in Charlottesville with an estimated revenue of -, and. It has 10 competitors …See details»
Adial Pharmaceuticals CEO and Key Executive Team | Craft.co
Adial Pharmaceuticals's Director is Tony Goodman. Other executives include Kevin Schuyler, Vice Chairman & Lead Independent Director; James W. Newman, Director and 5 others. See …See details»
ADial Pharmaceuticals • UVA Licensing & Ventures Group
Info@adialpharma.com. phone: (434) 422-9800. website: www.adialpharma.com. Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development …See details»
Adial Pharmaceuticals Expands Intellectual Property Portfolio
May 1, 2025 --Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, …See details»
MEDICINES FOR ADDICTION - Adial Pharma
Jun 10, 2021 6 Kevin Schuyler, Vice Chairman & Lead Independent Director –Senior Managing Director, Cornerstone Partners, which manages public market investments for endowments, …See details»
ADial Pharmaceuticals Announces Strategic Partnership With
Nov 4, 2013 Contact Data William Stilley, CEO (434) 422-9800 ext. 103 wstilley@adialpharma.comSee details»
Adial Pharmaceuticals Inc. | About Adial
Page-template-default,page,page-id-16445,bridge-core-2.5.8,ajax_fade,page_not_loaded,,qode-theme-ver-24.3,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,wpb-js …See details»
Pipeline – Adial Pharmaceuticals Inc.
Close Phase 3. Phase 3 trials are conducted in patients with the disease. They are intended both to demonstrate the drug candidate’s positive effect in treating the target disease or disorder …See details»